Raydiant Oximetry, Inc.

About Raydiant Oximetry, Inc.

Raydiant Oximetry is a clinical-stage medical device company focused on revolutionizing labor and delivery by developing innovative fetal monitoring technologies to improve outcomes for mothers and babies during childbirth. Their mission is to reduce mortality and morbidity rates by providing more accurate tools for evaluating fetal oxygenation.

Products & Services

Lumerah™:A noninvasive fetal pulse oximeter designed to directly measure fetal oxygen levels, offering improved sensitivity and specificity in detecting fetal distress, aiding healthcare professionals in decision-making during labor, and granted FDA Breakthrough Device status for fast-tracked market approval.

Specialties

Fetal Monitoring Noninvasive Sensor Technology Fetal Pulse Oximetry Biophotonics Machine Learning

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 7500000 MR: - FA: 7.5 million FAN: 7500000	D: 2024-06-04 FD: 2024-06-04	5 investors

Series A Latest

2024-06-04

$7.5M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mike Nagel

CEO

LinkedIn (Pro only)

R

Russ DeLonzor

COO and President

LinkedIn (Pro only)

D

Debra Snowdale

CFO

LinkedIn (Pro only)

M

Mark Rosen

Chief Medical Officer

P

Paul Stetson

Chief Scientific Officer

E

Eric Johansson

VP, R&D

View 22 more team members with Pro

Unlock Full Team Directory

Recent News